← Leaderboards
Traci A Wilgus
Loyola University Chicago
$3,112,771
Attributed
$3,112,771
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $505.2K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,112,771 · 6
By mechanism
R21$1,593,090 · 4
R01$1,439,104 · 1
F32$80,577 · 1
Top collaborators
No co-investigators on record.
Most similar at Loyola University Chicago
Same institution · by research overlap
- Liang Qiao$4,617,387
- Howard P Greisler$2,049,793
- Mitchell F Denning$2,127,484
- Maurizio Bocchetta$1,786,710
- M. Rita Young$5,685,619
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventSkinCicatrixMediator Of Activation ProteinCell TypeReceptorMouse ModelWound HealingOperative Surgical ProceduresLesionCase StudyCancer DiagnosisKnockout MiceResearch StudyKeratinocyteChronicIn VivoExposure ToCutaneousGrowth And Development FunctionAngiogenesisIn VitroMalignant NeoplasmsNeoplasm Metastasis
Grant awards (17)
Understanding the role of VEGF in scar formation$205,821
R21 · FY2022 · AR · contact PI
Understanding the role of VEGF in scar formation$173,250
R21 · FY2021 · AR · contact PI
Evaluation of a novel pro-fibrotic regulatory pathway in the skin$171,233
R21 · FY2018 · AR · contact PI
Evaluation of a novel pro-fibrotic regulatory pathway in the skin$204,160
R21 · FY2017 · AR · contact PI
Interleukin-33 in skin carcinogenesis$192,500
R21 · FY2015 · ES · contact PI
Interleukin-33 in skin carcinogenesis$230,563
R21 · FY2014 · ES · contact PI
Mast cells and immunosuppression in skin cancer$186,813
R21 · FY2013 · ES · contact PI
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis$276,450
R01 · FY2012 · CA · contact PI
Mast cells and immunosuppression in skin cancer$228,750
R21 · FY2012 · ES · contact PI
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis$276,450
R01 · FY2011 · CA · contact PI
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis$1
R01 · FY2010 · CA · contact PI
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis$285,000
R01 · FY2009 · CA · contact PI
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis$18,336
R01 · FY2009 · CA · contact PI
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis$285,000
R01 · FY2008 · CA · contact PI
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis$297,867
R01 · FY2007 · CA · contact PI
VEGF-induced angiogenesis and scar formation$33,281
F32 · FY2005 · GM
VEGF-induced angiogenesis and scar formation$47,296
F32 · FY2004 · GM